EX-4.5




 Exhibit 4.5 

DESCRIPTION OF REGISTRANT’S SECURITIES 

REGISTERED PURSUANT TO SECTION 12 OF 

THE SECURITIES EXCHANGE ACT OF 1934 

The following summary of the material terms of our securities is not intended to be a complete summary of the rights and preferences of
such securities, and is qualified by reference to Fisker Inc.’s Second Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), the Bylaws and the warrant-related documents described herein, which are
exhibits to Fisker Inc.’s Annual Report on Form 10-K for the year ended December 31, 2020. We encourage you to read each of the Certificate of Incorporation, the Bylaws, the warrant-related documents
described herein and the applicable provisions of the Delaware General Corporation Law (“DGCL”) in their entirety for a complete description of the rights and preferences of our securities. 

On October 29, 2020 (the “Closing Date”), Spartan Energy Acquisition Corp., our predecessor company, consummated the previously
announced merger pursuant to that certain Business Combination Agreement, dated July 10, 2020 (the “Business Combination Agreement”), by and among Spartan, Spartan Merger Sub Inc., a wholly-owned subsidiary of Spartan incorporated in
the State of Delaware (“Merger Sub”), and Fisker Group Inc. (f/k/a Fisker Inc.), a Delaware corporation (“Legacy Fisker”). Pursuant to the terms of the Business Combination Agreement, a Business Combination between the Company
and Legacy Fisker was effected through the merger of Merger Sub with and into Legacy Fisker, with Legacy Fisker surviving as the surviving company and as a wholly-owned subsidiary of Spartan (the “Merger” and, collectively with the other
transactions described in the Business Combination Agreement, the “Business Combination”). On the Closing Date, and in connection with the closing of the Business Combination (the “Closing”), Spartan Energy Acquisition Corp.
changed its name to Fisker Inc. 
 Unless the context indicates otherwise, references herein to the “Company,” “Fisker,”
“we,” “us,” “our” and similar terms refer to Fisker Inc. (f/k/a Spartan Energy Acquisition Corp.) and its consolidated subsidiaries (including Legacy Fisker). References to “Spartan” refer to our predecessor
company prior to the consummation of the Business Combination. Terms not otherwise defined herein are defined in the Company’s Form S-1 filed with the Securities and Exchange Commission (the
“SEC”) on December 1, 2020 (File Number 333-249981). 
 Authorized Capital Stock 

The Company is authorized to issue 915,000,000 shares of capital stock, consisting of three classes: 750,000,000 shares of
Class A common stock, $0.00001 par value per share (“Class A Common Stock”), 150,000,000 shares of Class B common stock, $0.00001 par value per share (“Class B Common Stock”), and 15,000,000 shares
of preferred stock, $0.00001 par value per share (“Preferred Stock”). 
 Common Stock 

As of December 31, 2020, there were 144,912,362 shares of Class A Common Stock outstanding, held of record by 97 stockholders.
As of December 31, 2020, there were 132,354,128 shares of Class B Common Stock outstanding, held of record by two stockholders. The Company’s Class A Common Stock and Public Warrants are listed on the New York Stock Exchange
under the symbols “FSR” and “FSR WS,” respectively. 
 The holders of Class A Common Stock are entitled to one vote
for each share held of record by such holder and each holder of Class B Common Stock has the right to ten votes per share of Class B Common Stock held of record by such holder on all matters submitted to a vote of the stockholders. The
holders of shares of Class A Common Stock and Class B Common Stock shall at all times vote together as a single class on all matters (including the election of directors) submitted to a vote of our stockholders; provided, however,
that, except as otherwise required by law, holders of shares of Class A Common Stock and Class B Common Stock shall not be entitled to vote on any amendment to the Certificate of Incorporation (including any certificate of designation
relating to any series of preferred stock) that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or
more other such series, to vote thereon pursuant to the Certificate of Incorporation (including any certificate of designation relating to 

  
 1 












 
any series of preferred stock). Subject to preferences that may be applicable to any outstanding Preferred Stock, holders of Common Stock are entitled to receive ratably such dividends as may be
declared by the Board of Directors of the Company (the “Board”) out of funds legally available for that purpose. In the event of liquidation, dissolution or winding up of the Company, the holders of Common Stock are entitled to share
ratably in all assets remaining after payment of liabilities, subject to the prior distribution rights of any outstanding Preferred Stock. The Common Stock has no preemptive or conversion rights or other subscription rights. The Class B Common
Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon
written notice to Fisker. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the
Certificate of Incorporation. 
 Preferred Stock 

The Board has the authority, without further action by the stockholders, to issue up to 15,000,000 shares of Preferred Stock, in one or
more series. The Board also has the authority to designate the rights, preferences, privileges and restrictions of each such series, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices,
liquidation preferences and the number of shares constituting any series. 
 The Certificate of Incorporation provides that shares of
Preferred Stock may be issued from time to time in one or more series. The Board is authorized to fix the designation, vesting, powers (including voting powers), preferences and relative, participating, optional or other rights (and the
qualifications, limitations or restrictions thereof) of the shares of each such series and to increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares of such series then
outstanding) the number of shares of any such series. The number of authorized shares of Preferred Stock may also be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a
majority of the voting power of all the then-outstanding shares of our capital stock entitled to vote thereon, without a separate vote of the holders of the Preferred Stock or any series thereof, unless a vote of any such holders is required
pursuant to the terms of any certificate of designation designating a series of Preferred Stock. 
 The Board will be able to, subject to
limitations prescribed by Delaware law, without stockholder approval, issue Preferred Stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the Common Stock and could have anti-takeover
effects. The ability of the Board to issue Preferred Stock without stockholder approval, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying,
deferring or preventing a change of control of the Company or the removal of our management and may adversely affect the market price of Class A Common Stock and the voting and other rights of the holders of the Company. As of December 31,
2020, there were no outstanding shares of Preferred Stock. 
 Warrants 

As of December 31, 2020, there were Public Warrants outstanding to purchase an aggregate of 18,400,000 shares of Class A Common
Stock, Private Warrants outstanding to purchase an aggregate of 9,360,000 shares of Class A Common Stock and Magna Warrants (as defined below) outstanding to purchase an aggregate of 19,474,454 shares of Class A Common Stock.

 Redemption of Warrants by Cashless Exercise. On March 19, 2021, the Company announced that it will redeem all of its
outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s Class A Common Stock, that were issued under the Warrant Agreement, dated August 9, 2018 (the “Warrant Agreement”), by and between
the Company (f/k/a Spartan Energy Acquisition Corp.) and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agent”), as part of the units sold in the Company’s initial public offering (the
“IPO”), for a redemption price of $0.01 per Public Warrant (the “Redemption Price”), that remain outstanding at 5:00 p.m. New York City time on April 22, 2021 (the “Redemption Date”). Warrants to purchase
Class A Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO are no longer outstanding and are not subject to redemption. In addition, in accordance with the Warrant Agreement, the Board
elected to require that, upon delivery of the notice of redemption, all Public Warrants are to be exercised only on a “cashless basis.” Accordingly, holders may no longer exercise Public Warrants and receive


  
 2 












 
Class A Common Stock in exchange for payment in cash of the $11.50 per warrant exercise price. Instead, a holder exercising a Public Warrant will be deemed to pay the $11.50 per warrant
exercise price by the surrender of 0.5046 of a share of Class A Common Stock that such holder would have been entitled to receive upon a cash exercise of a Public Warrant. Accordingly, by virtue of the cashless exercise of the Public Warrants,
exercising warrant holders will receive 0.4954 of a share of Class A Common Stock for each Public Warrant surrendered for exercise. Any Public Warrants (including Public Warrants that are included in outstanding units) that remain unexercised
at 5:00 p.m. New York City time on the Redemption Date will be delisted, void and no longer exercisable, and the holders will have no rights with respect to those Public Warrants, except to receive the Redemption Price (or as otherwise described in
the redemption notice for holders who hold their Public Warrants in “street name”) of $0.01 per outstanding warrant. 
 Public Warrants

 Each whole warrant entitles the registered holder to purchase one whole share of our Class A Common Stock at a price of $11.50
per share, subject to adjustment as discussed below, 30 days after the Closing, provided that the Company has an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”) covering the shares
of Class A Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the
warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrantholder may exercise its warrants
only for a whole number of shares of Class A Common Stock. This means that only a whole warrant may be exercised at any given time by a warrantholder. The warrants will expire on October 29, 2025 (which is five years after the completion
of the Business Combination), at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. 
 The Company is not
obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of
Class A Common Stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable and the Company
will not be obligated to issue shares of Class A Common Stock upon exercise of a warrant unless the Class A Common Stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of
the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise
such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a
unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A Common Stock underlying such unit. 

Once the warrants become exercisable, the Company may call the warrants for redemption: 

 

	 	•	 	 in whole and not in part; 



 

	 	•	 	 at a price of $0.01 per warrant; 



 

	 	•	 	 upon not less than 30 days’ prior written notice of redemption (the
“30-day redemption period”) to each warrantholder; and 


  

	 	•	 	 if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds $18.00 per share
(as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before we send the notice
of redemption to the warrantholders. 


 If and when the warrants become redeemable by the Company, it may exercise its
redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. 

  
 3 












 The Company has established the last of the redemption criterion discussed above to prevent
a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrantholder will be
entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A Common Stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. 

If the Company calls the warrants for redemption as described above, management of the Company will have the option to require any holder that
wishes to exercise his, her or its warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” management will consider, among other factors, the
Company’s cash position, the number of warrants that are outstanding and the dilutive effect on stockholders of issuing the maximum number of shares of Class A Common Stock issuable upon the exercise of the Company’s warrants. If
management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A Common Stock equal to the quotient obtained by dividing (x) the product of
the number of shares of Class A Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The
“fair market value” shall mean the average reported last sale price of the Class A Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of
warrants. If management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Class A Common Stock to be received upon exercise of the warrants, including the
“fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. The Company believes this feature is an attractive
option if it does not need the cash from the exercise of the warrants after the Business Combination. If the Company calls its warrants for redemption and management does not take advantage of this option, the Former Sponsor and its permitted
transferees would still be entitled to exercise their private placement warrants for cash or on a cashless basis using the same formula described above that other warrantholders would have been required to use had all warrantholders been required to
exercise their warrants on a cashless basis, as described in more detail below. 
 A holder of a warrant may notify the Company in writing
in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the
warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the shares of Class A Common Stock outstanding immediately after giving effect to such exercise. 

If the number of outstanding shares of Class A Common Stock is increased by a stock dividend payable in shares of Class A Common
Stock, or by a split-up of shares of Class A Common Stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the
number of shares of Class A Common Stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of Class A Common Stock. A rights offering to holders of Class A Common Stock
entitling holders to purchase shares of Class A Common Stock at a price less than the fair market value will be deemed a stock dividend of a number of shares of Class A Common Stock equal to the product of (i) the number of shares of
Class A Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A Common Stock) multiplied by (ii) one
(1) minus the quotient of (x) the price per share of Class A Common Stock paid in such rights offering divided by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or
exercisable for Class A Common Stock, in determining the price payable for Class A Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or
conversion and (ii) fair market value means the volume weighted average price of Class A Common Stock as reported during the ten trading day period ending on the trading day prior to the first date on which the shares of Class A
Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. 
 If the
number of outstanding shares of Class A Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Class A Common Stock or other similar event, then, on the effective date of such
consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Class A Common Stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of
Class A Common Stock. 

  
 4 












 Whenever the number of shares of Class A Common Stock purchasable upon the exercise of
the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of
Class A Common Stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of Class A Common Stock so purchasable immediately thereafter. 

In case of any reclassification or reorganization of the outstanding shares of Class A Common Stock (other than those described above or
that solely affects the par value of such shares of Class A Common Stock), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the
continuing corporation and that does not result in any reclassification or reorganization of outstanding shares of Class A Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property
of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions
specified in the warrants and in lieu of the shares of Class A Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or
property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised
his, her or its warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of Class A Common Stock in such a transaction is payable in the form of common stock in the successor entity that is
listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately
following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement
based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the
exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants. The warrant exercise price will not be adjusted for other events. 

The warrants have been issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as
warrant agent, and the Company. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at
least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. 

The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable
to the Company, for the number of warrants being exercised. The warrantholders do not have the rights or privileges of holders of Class A Common Stock or any voting rights until they exercise their warrants and receive shares of Class A
Common Stock. After the issuance of shares of Class A Common Stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders. 

No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a
fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number of shares of Class A Common Stock to be issued to the warrantholder. 

Private Warrants 
 The private placement
warrants (including the shares of Class A Common Stock issuable upon exercise of the private placement warrants) are not transferable, assignable or salable until 30 days after the Closing (except, among other limited exceptions, to
officers and directors of the Company and other persons or entities affiliated with 

  
 5 












 
the Former Sponsor), and they will not be redeemable by the Company so long as they are held by the Former Sponsor or its permitted transferees. The Former Sponsor, or its permitted transferees,
has the option to exercise the private placement warrants on a cashless basis. Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants sold as part of the units in the IPO,
including as to exercise price, exercisability and exercise period. If the private placement warrants are held by holders other than the Former Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company
and exercisable by the holders on the same basis as the warrants included in the units sold in the IPO. 
 If holders of the private
placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of shares of Class A Common Stock equal to the quotient obtained by dividing (x) the
product of the number of shares of Class A Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value.
The “fair market value” shall mean the average reported last sale price of the Class A Common Stock for the ten trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the
warrant agent. 
 Magna Warrants 
 On
October 29, 2020, the Company issued warrants exercisable for up to 19,474,454 shares of the Company’s Class A Common Stock to Magna International Inc. (the “Magna Warrants”), subject to adjustment, in a private
placement pursuant to the exemption from the registration requirements of the Securities Act provided by Section 4(a)(2) of the Securities Act. The Magna Warrants were issued in connection with a Cooperation Agreement entered into by the
Company and Magna International Inc., the holder of the Magna Warrants (the “Holder”), dated October 15, 2020. 
 The Magna
Warrants are subject to vesting as follows: 
  

					
	 Milestones
	  	Percentage of Warrants that
Vest Upon Achievement	 
	 (i) Achievement of the “preliminary production specification” gateway as set forth
in the Development Agreement; (ii) entering into the Platform Agreement; and (iii) entering into the Initial Manufacturing Agreement
	  	 	33.3	% 
	 (i) Achievement of the “target agreement” gateway as set forth in the Development
Agreement and (ii) entering into the Detailed Manufacturing Agreement, which will contain terms and conditions agreed to in the Initial Manufacturing
	  	 	33.3	% 
	 Start of pre-serial production
	  	 	33.4	% 

 The exercise price for the Magna Warrants is $0.01 per share of Class A Common Stock. The Magna Warrants
will vest in full upon a change of control of the Company. Once vested, the Magna Warrants may be exercised at the election of the Holder, in whole but not in part, by the tender to the Company of a notice of exercise. The Magna Warrants will expire
on October 29, 2030. 
 Lock-Up Restrictions 

Certain stockholders are subject to certain restrictions on transfer until the termination of applicable
lock-up periods. 
 Registration Rights 

The holders of the Founder Shares, Executive Shares, Private Warrants, Magna Warrants, certain Legacy Fisker shares and certain equity
securities that may be issued upon the conversion of certain working capital loans (and any shares of Class A Common Stock issuable upon the exercise of such equity securities and upon conversion of the Founder Shares), (collectively, the
“Reg Rights Holders”) will be entitled to registration rights pursuant to the 

  
 6 












 
A&R Registration Rights Agreement, dated as of October 29, 2020, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to
Class A Common Stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain
“piggy-back” registration rights with respect to registration statements filed subsequent to completion of the Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under
the Securities Act. 
 Pursuant to the A&R Registration Rights Agreement, the Company agreed that, within 30 calendar days after the Closing, it
will file a registration statement with the SEC (at its sole cost and expense), and it will use its reasonable best efforts to have the registration statement become effective as soon as reasonably practicable after the filing thereof. Additionally,
the Company agreed that, as soon as reasonably practicable after it is eligible to register the Reg Rights Holders’ securities on a registration statement on Form S-3, it will file the registration
statement with the SEC (at its sole cost and expense) and it will use its reasonable best efforts to have the registration statement become effective as soon as reasonably practicable after the filing thereof. In certain circumstances, the Reg
Rights Holders can demand up to three underwritten offerings and will be entitled to customary piggyback registration rights. The A&R Registration Rights Agreement does not provide for the payment of any cash penalties by the Company if it fails
to satisfy any of its obligations under the A&R Registration Rights Agreement. 
 Pursuant to the Subscription Agreements entered into
as part of the PIPE Financing, the Company agreed that, within 30 calendar days after the consummation of the Business Combination, the Company will file with the SEC (at its sole cost and expense) a registration statement registering the
resale of the PIPE Shares (the “PIPE Resale Registration Statement”), and that the Company will use its commercially reasonable efforts to have the PIPE Resale Registration Statement declared effective as soon as practicable after the
filing thereof. 
 Delaware Anti-Takeover Law and Certificate of Incorporation and Bylaw Provisions 

Under Section 203 of the DGCL, the Company will be prohibited from engaging in any business combination with any stockholder for a period
of three years following the time that such stockholder (the “interested stockholder”) came to own at least 15% of our outstanding voting stock (the “acquisition”), except if: 

 

	 	•	 	 the Board approved the acquisition prior to its consummation; 



 

	 	•	 	 the interested stockholder owned at least 85% of the outstanding voting stock upon consummation of the
acquisition; or 


  

	 	•	 	 the business combination is approved by the Board, and by a 2/3 majority vote of the other stockholders in a
meeting. 


 Generally, a “business combination” includes any merger, consolidation, asset or stock sale or
certain other transactions resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an “interested stockholder” is a person who, together with that person’s affiliates and associates, owns, or
within the previous three years owned, 15% or more of our voting stock. 
 Under certain circumstances, declining to opt out of
Section 203 of the DGCL will make it more difficult for a person who would be an “interested stockholder” to effect various business combinations with the Company for a three-year period. This may encourage companies interested in
acquiring the Company to negotiate in advance with the Board because the stockholder approval requirement would be avoided if the Board approves the acquisition which results in the stockholder becoming an interested stockholder. This may also have
the effect of preventing changes in the Board and may make it more difficult to accomplish transactions which stockholders may otherwise deem to be in their best interests. 

  
 7 












 Written Consent by Stockholders 

Under the Certificate of Incorporation, subject to the rights of any series of Preferred Stock then outstanding, any action required or
permitted to be taken by stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by any consent in writing by such stockholders. 

Special Meeting of Stockholders 
 Under
the Certificate of Incorporation, special meetings of stockholders may be called only by the chairperson of the Board, the chief executive officer or the Board acting pursuant to a resolution adopted by a majority of the total number of authorized
directors whether or not there exist any vacancies in previously authorized directorships, and may not be called by any other person or persons. Only such business shall be considered at a special meeting of stockholders as shall have been stated in
the notice for such meeting. 
 Advance Notice Requirements for Stockholder Proposals and Director Nominations 

Under the Certificate of Incorporation, advance notice of stockholder nominations for the election of directors and of business to be brought
by stockholders before any meeting of stockholders shall be given in the manner and to the extent provided in the Bylaws. 
 Rule 144 

Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell
companies) or issuers that have been at any time previously a shell company, such as the Company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met: 

 

	 	•	 	 the issuer of the securities that was formerly a shell company has ceased to be a shell company;



  

	 	•	 	 the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”); 


  

	 	•	 	 the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable,
during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and 



 

	 	•	 	 at least one year has elapsed from the time that the issuer filed current Form 10 type information with the
SEC reflecting its status as an entity that is not a shell company. 


 Upon the Closing, the Company ceased to be a shell
company. 
 When and if Rule 144 becomes available for the resale of our securities, a person who has beneficially owned restricted
shares of our Common Stock or Warrants for at least six months would be entitled to sell their securities, provided that (i) such person is not deemed to have been one of the Company’s affiliates at the time of, or at any time during the
three months preceding, a sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during
the 12 months (or such shorter period as we were required to file reports) preceding the sale. 
 Persons who have beneficially owned
restricted shares of the Company’s Common Stock or Warrants for at least six months but who are affiliates at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such
person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of: 
  

	 	•	 	 one percent (1%) of the total number of shares of Common Stock then outstanding; or 



 

	 	•	 	 the average weekly reported trading volume of the Common Stock during the four calendar weeks preceding the
filing of a notice on Form 144 with respect to the sale. 



  
 8 












 Sales by affiliates under Rule 144 will also be limited by manner of sale provisions
and notice requirements and to the availability of current public information about the Company. 
 Transfer Agent and Registrar 

The transfer agent for Class A Common Stock and warrant agent for the Company’s warrants is Continental Stock Transfer &
Trust Company. The transfer agent and warrant agent’s telephone number and address is (212) 509-4000 and 1 State Street, 30th Floor, New York, NY 10004. 

  
 9